当前位置: 首页 > 期刊 > 《中国中药杂志》 > 2017年第12期 > 正文
编号:13046255
黄连素调控胰岛素抵抗相关2型糖尿病的研究进展(10)
http://www.100md.com 2017年6月15日 《中国中药杂志》2017年第12期
     [79] Everard A, Cani P D. Gut microbiota and GLP-1[J]. Rev Endocr Metab Disord,2014,15(3):189.

    [80] Menzel T, Luhrs H, Zirlik S, et al. Butyrate inhibits leukocyte adhesion to endothelial cells via modulation of VCAM-1[J]. Inflamm Bowel Dis,2004,10(2):122.

    [81] Duncan S H, Belenguer A, Holtrop G, et al. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces[J]. Appl Environ Microbiol,2007,73(4):1073.

    [82] Liu J, Pang Z P. Glucagon-like peptide-1 drives energy metabolism on the synaptic highway[J]. FEBS J,2016,283(24):4413.

    [83] Delzenne N M, Cani P D. Nutritional modulation of gut microbiota in the context of obesity and insulin resistance: potential interest of prebiotics[J]. Int Dairy J,2010,20(4):277.

    [84] Yu Y, Liu L, Wang X, et al. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies[J]. Biochem Pharmacol,2010,79(7):1000.

    [85] Zhang Q, Xiao X, Li M, et al. Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine[J]. BMC Complement Altern Med,2014,14(1):188.

    [86] Sun H, Wang N, Cang Z, et al. Modulation of microbiota-gut-brain axis by berberine resulting in improved metabolic status in high-fat diet-fed rats[J]. Obes Facts,2016,9(6):365.

    [責任编辑 曹阳阳] (李骋 何金枝 周学东 徐欣)
上一页1 2 3 4 5 6 7 8 9 10